Calling all Cardiologists
ARC is supporting a Satellite Symposium at the Heart Failure Society of America (HFSA) Meeting, 4-6pm, September 17, 2016.
Cardiologists miss the diagnosis of amyloidosis more frequently than any other discipline. Don’t be one of them. Join ARC for an exciting CME Satellite Symposium at HFSA, entitled Cardiac Amyloidosis: A Multidisciplinary Approach to Understanding, Diagnosis and Treatment. The distinguished panel of speakers includes:
Mark Semigran, MD Associate Professor of Medicine, Harvard Medical School, Medical Director, Heart Failure and Cardiac Transplant Program, Massachusetts General Hospital
Martha Grogan, MD Assistant Professor of Medicine, Mayo Medical School, Department of Cardiovascular Diseases, Mayo Clinic
Frederick Ruberg, MD Associate Professor of Medicine and Radiology, Boston University School of Medicine, Director, Advanced Cardiac Imaging Program Section of Cardiovascular Medicine and Amyloidosis Center, Department of Medicine, Boston Medical Center
James Stone, MD, PhD Associate Professor of Pathology, Harvard Medical School, Head of Cardiovascular Pathology, Department of Pathology, Massachusetts General Hospital
Angela Dispenzieri, MD Professor of Medicine, Professor of Laboratory Medicine and Pathology, Mayo Medical School Division of Hematology, Department of Internal Medicine, Mayo Clinic
- Categories
- Lastest Posts
- FDA Approves Attruby™ (acoramidis) for the Treatment of ATTR-CM: A New Option for Patients
- ARC Launches Clinical Fellowship Program to Advance Amyloidosis Care
- The More Things Change, the More They Stay the Same
- The Inflation Reduction Act: The Devil is in the Details for Patients with Rare Diseases